A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
American Society of Clinical Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Immunocore Ltd
M.D. Anderson Cancer Center
Ann & Robert H Lurie Children's Hospital of Chicago
Mayo Clinic
Shanghai Henlius Biotech
University Hospital, Essen
M.D. Anderson Cancer Center
Exelixis
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
AstraZeneca
NYU Langone Health
Federation Francophone de Cancerologie Digestive
Pfizer
M.D. Anderson Cancer Center
Bristol-Myers Squibb
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Netherlands Cancer Institute
National Cancer Institute (NCI)
University of Chicago
Canadian Cancer Trials Group
AstraZeneca
Bristol-Myers Squibb
Georgetown University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Institute of Oncology Ljubljana
Dana-Farber Cancer Institute